This trial will compare a targeted multidomain intervention to usual care in military-aged civilians with complex mTBI to see which is more effective.
3 Primary · 13 Secondary · Reporting Duration: The BSI-18 will be measured from baseline to 3 months.
Active Control
Experimental Treatment
250 Total Participants · 2 Treatment Groups
Primary Treatment: Targeted Multidomain · No Placebo Group · N/A
Age 18 - 49 · All Participants · 6 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: